DaVita, Inc. (NYSE:DVA)

CAPS Rating: 3 out of 5

The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.

Recs

0
Player Avatar CashCowReturns (59.54) Submitted: 1/22/2007 11:34:21 AM : Outperform Start Price: $53.29 DVA Score: +54.79

BW 2007 Picks

Report this Post Reply

Featured Broker Partners


Advertisement